Trial · NCT03223428
Results by group30
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 30
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Percentage of Patients Who Are Satisfied With Their Overall Symptom Control | Carcinoid Syndrome Patients Initiating Xermelo | Very Satisfied with symptom control | 37 | Participants | |
| Percentage of Patients Who Are Satisfied With Their Overall Symptom Control | Carcinoid Syndrome Patients Initiating Xermelo | Somewhat satisfied with symptom control | 58 | Participants | |
| Percentage of Patients Who Are Satisfied With Their Overall Symptom Control | Carcinoid Syndrome Patients Initiating Xermelo | Neither satisfied or dissatisfied with symptom control | 22 | Participants | |
| Percentage of Patients Who Are Satisfied With Their Overall Symptom Control | Carcinoid Syndrome Patients Initiating Xermelo | Somewhat dissatisfied with symptom control | 5 | Participants | |
| Percentage of Patients Who Are Satisfied With Their Overall Symptom Control | Carcinoid Syndrome Patients Initiating Xermelo | Very dissatisfied with symptom control | 3 | Participants | |
| Percentage of Patients Reporting Satisfaction of CS-related Diarrhea Control | Carcinoid Syndrome Patients Initiating Xermelo | Very satisfied | 46 | Participants | |
| Percentage of Patients Reporting Satisfaction of CS-related Diarrhea Control | Carcinoid Syndrome Patients Initiating Xermelo | Somewhat satisfied | 51 | Participants | |
| Percentage of Patients Reporting Satisfaction of CS-related Diarrhea Control | Carcinoid Syndrome Patients Initiating Xermelo | Neither satisfied nor dissatisfied | 12 | Participants | |
| Percentage of Patients Reporting Satisfaction of CS-related Diarrhea Control | Carcinoid Syndrome Patients Initiating Xermelo | Somewhat dissatisfied | 11 | Participants | |
| Percentage of Patients Reporting Satisfaction of CS-related Diarrhea Control | Carcinoid Syndrome Patients Initiating Xermelo | Very dissatisfied | 5 | Participants | |
| Percentage of Patients Reporting Satisfaction of CS- Related Flushing Control | Carcinoid Syndrome Patients Initiating Xermelo | Very satisfied | 24 | Participants | |
| Percentage of Patients Reporting Satisfaction of CS- Related Flushing Control | Carcinoid Syndrome Patients Initiating Xermelo | Somewhat satisfied | 39 | Participants | |
| Percentage of Patients Reporting Satisfaction of CS- Related Flushing Control | Carcinoid Syndrome Patients Initiating Xermelo | Neither satisfied nor dissatisfied | 34 | Participants | |
| Percentage of Patients Reporting Satisfaction of CS- Related Flushing Control | Carcinoid Syndrome Patients Initiating Xermelo | Somewhat dissatisfied | 7 | Participants | |
| Percentage of Patients Reporting Satisfaction of CS- Related Flushing Control | Carcinoid Syndrome Patients Initiating Xermelo | Very dissatisfied | 4 | Participants | |
| Number of Patients Reporting Reduction in Rescue SSA Use | Carcinoid Syndrome Patients Initiating Xermelo | 21 | participants | ||
| Percentage of Patients Reporting Reduction in the Dose of Long-acting SSA Injection | Carcinoid Syndrome Patients Initiating Xermelo | 7 | Participants | ||
| Percentage of Patients Reporting Reduction in the Frequency of Long-acting SSA Injection | Carcinoid Syndrome Patients Initiating Xermelo | 9 | Participants | ||
| Percentage of Patients Reporting an Overall Improvement in CS Symptom Control Based on Patient Global Impression of Change (PGIC) | Carcinoid Syndrome Patients Initiating Xermelo | Very much improved | 20 | Participants | |
| Percentage of Patients Reporting an Overall Improvement in CS Symptom Control Based on Patient Global Impression of Change (PGIC) | Carcinoid Syndrome Patients Initiating Xermelo | Much improved | 28 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03223428/results